LIR and Resilience partner to develop affordable obesity treatments via transdermal patches.

LIR Life Sciences Corp. has entered a six-month collaboration with Resilience BioSciences Inc. to advance obesity treatments at the University of British Columbia. The partnership involves early-stage research on transdermal patches and aims to create affordable, needle-free therapies.